Duality Advisers’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-65,248
Closed -$4.64M 594
2023
Q3
$4.64M Buy
65,248
+41,502
+175% +$3.1M 0.56% 22
2023
Q2
$1.83M Buy
+23,746
New +$1.84M 0.23% 171
2022
Q4
Sell
-10,334
Closed -$726K 612
2022
Q3
$726K Buy
+10,334
New +$810K 0.08% 354
2022
Q2
Sell
-75,569
Closed -$5.73M 632
2022
Q1
$5.73M Buy
+75,569
New +$5.99M 0.62% 2
2021
Q4
Sell
-4,186
Closed -$316K 518
2021
Q3
$316K Buy
+4,186
New +$332K 0.02% 477
2021
Q2
Sell
-22,134
Closed -$1.75M 559
2021
Q1
$1.75M Buy
+22,134
New +$1.73M 0.15% 243
2020
Q4
Sell
-60,200
Closed -$4.64M 577
2020
Q3
$4.64M Buy
60,200
+21,476
+55% +$1.64M 0.3% 68
2020
Q2
$2.84M Buy
+38,724
New +$2.75M 0.26% 109
2019
Q4
Sell
-91,900
Closed -$6.76M 386
2019
Q3
$6.76M Sell
91,900
-210,020
-70% -$15.2M 0.38% 76
2019
Q2
$21.6M Buy
301,920
+137,950
+84% +$9.79M 1.9% 7
2019
Q1
$11.2M Buy
+163,970
New +$10.6M 0.66% 32

Other funds holding CL

Duality Advisers's CL Position: Q4 2023 in Review

Duality Advisers sold out of Colgate-Palmolive (CL) in Q4 2023, closing a stake of 65,248 shares — an estimated $4.64M sold.

Duality Advisers first reported a position in CL in Q1 2019 and held it in 11 quarters. The position peaked at $21.6M in Q2 2019. 1,741 funds tracked by Wall St. Rank hold CL as of Q4 2023.

  • Duality Advisers reported no remaining Colgate-Palmolive position as of Q4 2023 after selling out during the quarter.
  • Duality Advisers sold 65,248 Colgate-Palmolive shares in Q4 2023, an estimated $4.64M.
  • Duality Advisers first reported a position in Colgate-Palmolive in Q1 2019 and held it in 11 quarters.
  • Duality Advisers's Colgate-Palmolive position peaked at $21.6M in Q2 2019.
  • 1,741 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2023.

Based on Duality Advisers's 13F filing for Q4 2023, filed 1 Feb 2024.